These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33150699)

  • 1. Exit site infection and peritonitis due to Serratia species in patients receiving peritoneal dialysis: Epidemiology and clinical outcomes.
    Au CWH; Yap DYH; Chan JFW; Yip TPS; Chan TM
    Nephrology (Carlton); 2021 Mar; 26(3):255-261. PubMed ID: 33150699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkholderia cepacia Exit-Site Infection in Peritoneal Dialysis Patients-Clinical Characteristics and Treatment Outcomes.
    Yap DY; Chan JF; Yip T; Mok MM; Kwan LP; Lo WK; Chan TM
    Perit Dial Int; 2016; 36(4):390-4. PubMed ID: 26493755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.
    Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG
    Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
    Sachar M; Shah A
    Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.
    Sethna CB; Bryant K; Munshi R; Warady BA; Richardson T; Lawlor J; Newland JG; Neu A;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1590-1596. PubMed ID: 27340282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
    Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
    Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing
    Kilic I; Gungor K; Kurultak I; Ustundag S
    Saudi J Kidney Dis Transpl; 2018; 29(6):1494-1497. PubMed ID: 30588985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.
    van Esch S; Krediet RT; Struijk DG
    Perit Dial Int; 2014; 34(2):162-70. PubMed ID: 24584620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and Clinical Characteristics of
    Li PH; Cheng VC; Yip T; Yap DY; Lui SL; Lo WK
    Perit Dial Int; 2017; 37(2):177-182. PubMed ID: 27680764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exit-Site Relocation: A Novel, Straightforward Technique for Exit-Site Infections.
    Kirmizis D; Bowes E; Ansari B; Cairns H
    Perit Dial Int; 2019; 39(4):350-355. PubMed ID: 31123073
    [No Abstract]   [Full Text] [Related]  

  • 17. Technique survival with Serratia peritonitis.
    Hiremath S; Biyani M
    Adv Perit Dial; 2006; 22():73-6. PubMed ID: 16983944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [